Bio-Connect

Interferon gamma Receptor 1 antibody [BB1E2]

GTX11285
GeneTex
ApplicationsFlow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
Product group Antibodies
TargetIFNGR1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Interferon gamma Receptor 1 antibody [BB1E2]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1microg/ml. IHC-Fr: 1-10microg/ml. FACS: 1-10microg/ml. ELISA: 1microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    BB1E2
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID3459
  • Target name
    IFNGR1
  • Target description
    interferon gamma receptor 1
  • Target synonyms
    CD119, IFNGR, IMD27A, IMD27B, interferon gamma receptor 1, AVP, type 2, CD119 antigen, CDw119, IFN-gamma receptor 1, IFN-gamma-R-alpha, IFN-gamma-R1, antiviral protein, type 2, immune interferon receptor 1, interferon-gamma receptor alpha chain
  • Host
    Mouse
  • Isotype
    IgG2a
  • Protein IDP15260
  • Protein Name
    Interferon gamma receptor 1
  • Scientific Description
    This gene (IFNGR1) encodes the ligand-binding chain (alpha) of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. A genetic variation in IFNGR1 is associated with susceptibility to Helicobacter pylori infection. In addition, defects in IFNGR1 are a cause of mendelian susceptibility to mycobacterial disease, also known as familial disseminated atypical mycobacterial infection. [provided by RefSeq, Jul 2008]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • miR-4666-3p and miR-329 Synergistically Suppress the Stemness of Colorectal Cancer Cells via Targeting TGF-beta/Smad Pathway. Ye J et al., 2019, Front Oncol
    Read more